Prosecution Insights
Prosecution Insights
22 pending office actions • 17 art units • 22 examiners • 0 of 22 (0%) have an AI response strategy ready • 30 patents granted in the last 365 days
Based on the USPTO statutory response window for each pending office action. 16 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 16 of the docket's apps have a known mailing date.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 + other | 1 (5%) |
| §103 only | 3 (14%) |
| §102 only | 3 (14%) |
| §112 only | 2 (9%) |
| Double-patenting + other | 3 (14%) |
| Multi-statute (no §101) | 10 (45%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| ABBOTT-LEWIS, YVONNE RENEE | 1 | 78.3% | +7.9% |
| IBRAHIM, MEDINA AHMED | 1 | 87.3% | +12.2% |
| CATINA, MICHAEL ANTHONY | 1 | 31.3% | +30.3% |
| NATARAJAN, MEERA | 1 | 62.3% | +17.6% |
| HEASLEY, MEGHAN CHRISTINE | 1 | 76.6% | +34.8% |
| LIN, ERICA S Y | 1 | 85.9% | +2.6% |
| DELEO, VICTORIA LYNN | 1 | 37.0% | -40.0% |
| LADD, CAROLYN LOUISE | 1 | 57.0% | +47.9% |
| NOTTINGHAM, KYLE GREGORY | 1 | 59.3% | +34.9% |
| BEANE, RANDALL L | 1 | 32.8% | +36.6% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 8 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18011453 | PROCESSES FOR ELECTROCHEMICAL UP-CYCLING OF PLASTICS AND SYSTEMS THEREOF | WONG, EDNA | 36d overdue |
| 18685163 | VACUUM CALORIMETER COMPRISING AN OPEN SYSTEM DIFFERENTIAL CALORIMETER | LIN, ERICA S Y | 11d overdue |
| 17290987 | NOVEL SELECTIVE KAPPA OPIOID RECEPTOR ANTAGONISTS AND METHODS RELATED THERETO | SEITZ, ANTHONY JOSEPH | 11d overdue |
| 17782768 | METHOD AND COMPOSITIONS FOR ENGINEERING GRAPEVINE RED BLOTCH VIRUS-RESISTANT GRAPEVINE | RADOSAVLJEVIC, ALEKSANDAR | 13d |
| 18290113 | TISSUE-CULTURE INDEPENDENT GENE EDITING OF CELLS BY A LONG-DISTANCE RNA TRANSPORT SYSTEM | DELEO, VICTORIA LYNN | 77d |
| 17956249 | DISULFIRAM AND OTHER REDOX-RELATED COMPOSITIONS FOR BRAIN TUMORS | BORI, IBRAHIM D | 86d |
| 19172058 | AUTOMATED CANINE LINE-UP FOR DETECTION DOG RESEARCH | ABBOTT-LEWIS, YVONNE RENEE | — |
| 18993995 | MODIFIED PLANTS AND SEEDS WITH ENHANCED PHYSIOLOGICAL PERFORMANCE AND ENVIRONMENTAL STRESS RESISTANCE | IBRAHIM, MEDINA AHMED | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 7 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18256449 | BCAA-Lowering Compounds for Prevention and/or Treatment of Alzheimer's Disease and Related Disorders | LADD, CAROLYN LOUISE | 13d |
| 18323277 | SUBSTITUTED BISPHENYLALKYLUREA COMPOUNDS AND METHODS OF TREATING INFLAMMATORY CONDITIONS | NOTTINGHAM, KYLE GREGORY | 83d |
| 18993995 | MODIFIED PLANTS AND SEEDS WITH ENHANCED PHYSIOLOGICAL PERFORMANCE AND ENVIRONMENTAL STRESS RESISTANCE | IBRAHIM, MEDINA AHMED | — |
| 18741371 | FOUR-COMPARTMENT CONTROLLER MODEL OF MUSCLE FATIGUE FOR ALL ACTIVITY TYPES | CATINA, MICHAEL ANTHONY | — |
| 18694966 | GFRA2 ANTIBODIES AND THEIR USE IN CANCER TREATMENT | NATARAJAN, MEERA | — |
| 18688767 | PREPARATION OF IONIC PHARMACEUTICAL COCRYSTALS USING SOLID AND LIQUID COMPONENTS | HEASLEY, MEGHAN CHRISTINE | — |
| 18038177 | METHODS OF TREATING OR PREVENTING NEUROLOGICAL DISORDERS USING ZPR1 | BEANE, RANDALL L | — |
| Art Unit | Apps |
|---|---|
| 1629 | 3 |
| 1662 | 2 |
| 3644 | 1 |
| 3791 | 1 |
| 1626 | 1 |
| 2853 | 1 |
| 1622 | 1 |
| 1621 | 1 |
| 1654 | 1 |
| 1795 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 19172058 | AUTOMATED CANINE LINE-UP FOR DETECTION DOG RESEARCH | ABBOTT-LEWIS, YVONNE RENEE | 3644 | §102§103 | Non-Final OA | — | Pending | Apr 07, 2025 |
| 18993995 | MODIFIED PLANTS AND SEEDS WITH ENHANCED PHYSIOLOGICAL PERFORMANCE AND ENVIRONMENTAL STRESS RESISTANCE | IBRAHIM, MEDINA AHMED | — | §102§103§112 | Non-Final OA | — | Pending | Jan 13, 2025 |
| 18741371 | FOUR-COMPARTMENT CONTROLLER MODEL OF MUSCLE FATIGUE FOR ALL ACTIVITY TYPES | CATINA, MICHAEL ANTHONY | 3791 | §101§112 | Non-Final OA | — | Pending | Jun 12, 2024 |
| 18694966 | GFRA2 ANTIBODIES AND THEIR USE IN CANCER TREATMENT | NATARAJAN, MEERA | — | §112 | Non-Final OA | — | Pending | Mar 23, 2024 |
| 18688767 | PREPARATION OF IONIC PHARMACEUTICAL COCRYSTALS USING SOLID AND LIQUID COMPONENTS | HEASLEY, MEGHAN CHRISTINE | 1626 | §102§103 | Non-Final OA | — | Pending | Mar 02, 2024 |
| 18685163 | VACUUM CALORIMETER COMPRISING AN OPEN SYSTEM DIFFERENTIAL CALORIMETER | LIN, ERICA S Y | 2853 | §102§103§112 | Non-Final OA | 11d overdue | Pending | Feb 20, 2024 |
| 18290113 | TISSUE-CULTURE INDEPENDENT GENE EDITING OF CELLS BY A LONG-DISTANCE RNA TRANSPORT SYSTEM | DELEO, VICTORIA LYNN | 1662 | §103§112 | Final Rejection | 77d | Pending | Nov 09, 2023 |
| 18256449 | BCAA-Lowering Compounds for Prevention and/or Treatment of Alzheimer's Disease and Related Disorders | LADD, CAROLYN LOUISE | 1622 | §112 | Final Rejection | 13d | Pending | Jun 08, 2023 |
| 18323277 | SUBSTITUTED BISPHENYLALKYLUREA COMPOUNDS AND METHODS OF TREATING INFLAMMATORY CONDITIONS | NOTTINGHAM, KYLE GREGORY | 1621 | §102§112DP | Non-Final OA | 83d | Pending | May 24, 2023 |
| 18038177 | METHODS OF TREATING OR PREVENTING NEUROLOGICAL DISORDERS USING ZPR1 | BEANE, RANDALL L | 1654 | §102§103§112 | Non-Final OA | — | Pending | May 22, 2023 |
| 18037732 | THERAPIES FOR CANCER USING SMALL MOLECULES THAT BIND TO AND INHIBIT RAL INTERACTING PROTEINS | YOUNGBLOOD, WILLIAM JUSTIN | 1629 | §102 | Non-Final OA | 35d | Pending | May 18, 2023 |
| 18011453 | PROCESSES FOR ELECTROCHEMICAL UP-CYCLING OF PLASTICS AND SYSTEMS THEREOF | WONG, EDNA | 1795 | §103§112 | Final Rejection | 36d overdue | Pending | Dec 19, 2022 |
| 17956249 | DISULFIRAM AND OTHER REDOX-RELATED COMPOSITIONS FOR BRAIN TUMORS | BORI, IBRAHIM D | 1629 | §102§112 | Non-Final OA | 86d | Pending | Sep 29, 2022 |
| 17909480 | TARGETING JUNCTIONAL EPITHELIUM IN THE GINGIVAL CREVICE FOR IMMUNE MODULATION | FUBARA, BLESSING M | 1613 | §103§112DPOther | Non-Final OA | 68d | Pending | Sep 06, 2022 |
| 17908999 | MODIFIED TETRACYCLINES FOR TREATMENT OF ALCOHOL USE DISORDER, PAIN AND OTHER DISORDERS INVOLVING POTENTIAL INFLAMMATORY PROCESSES | HOWELL, THEODORE R | 1628 | §102DPOther | Final Rejection | 71d | Pending | Sep 02, 2022 |
| 17908497 | COMPOSITIONS AND METHODS FOR REPELLING ANIMALS FROM AN OBJECT | SHIN, MONICA A | 1616 | §103 | Final Rejection | 99d overdue | Pending | Aug 31, 2022 |
| 17782768 | METHOD AND COMPOSITIONS FOR ENGINEERING GRAPEVINE RED BLOTCH VIRUS-RESISTANT GRAPEVINE | RADOSAVLJEVIC, ALEKSANDAR | 1662 | §103§112 | Non-Final OA | 13d | Pending | Jun 06, 2022 |
| 17630975 | Microfluidic Pipette Aspirators for Large-Scale Analysis of Single Cells, Clusters and Their Sub-Populations | KRCHA, MATTHEW D | 1798 | §102 | Final Rejection | 126d overdue | Pending | Jan 28, 2022 |
| 17521773 | SYSTEM AND METHOD FOR ASSESSING EMBRYO VIABILITY | HUANG, MICKEY NMN | 1758 | §102 | Final Rejection | 29d | Pending | Nov 08, 2021 |
| 17290987 | NOVEL SELECTIVE KAPPA OPIOID RECEPTOR ANTAGONISTS AND METHODS RELATED THERETO | SEITZ, ANTHONY JOSEPH | 1629 | §102§112 | Final Rejection | 11d overdue | Pending | May 03, 2021 |
| 17284525 | Method to Express, Purify, and Biotinylate Eukaryotic Cell-Derived Major Histocompatibility Complexes | YAO, LEI | 1642 | §103 | Final Rejection | 35d overdue | Pending | Apr 12, 2021 |
| 16310981 | Method and Composition for Reducing Pathogens in Rendered Food Products Using Lactic Acid Bacteria | GOUGH, TIFFANY MAUREEN | 1651 | §103 | Final Rejection | 74d overdue | Pending | Dec 18, 2018 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial